|
Market Closed -
Nasdaq
01:30:00 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.310 USD | -2.24% |
|
-10.27% | -4.38% |
| Market Cap | 45Cr 40Cr 37Cr 34Cr 64Cr 4.3TCr 65Cr 448.22Cr 175.74Cr 2.24TCr 169.86Cr 166.24Cr 7.15TCr | P/E 2026 * |
-2.17x | P/E 2027 * | -2.04x |
|---|---|---|---|---|---|
| Enterprise Value | 26Cr 23Cr 21Cr 19Cr 36Cr 2.43TCr 37Cr 253.6Cr 99Cr 1.27TCr 96Cr 94Cr 4.04TCr | EV / Sales 2026 * |
75.3x | EV / Sales 2027 * | 25x |
| Free-Float |
88.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALLO | Delayed | |
CBOE
| ALLO | Real-time |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -2.24% | ||
| 1 week | -10.27% | ||
| Current month | -18.12% | ||
| 1 month | -22.49% | ||
| 3 months | -26.82% | ||
| 6 months | -44.73% | ||
| Current year | -4.38% |
| 1 week | 1.22 |  | 1.46 |
| 1 month | 1.22 | | 1.74 |
| Current year | 1.22 | | 4.46 |
| 1 year | 1.04 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 20.75 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
David Chang
BRD | Director/Board Member | 66 | 01/06/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/08/26 | Sell | Compliance Officer | -29,697 | 0.0086% | ||
| 01/07/26 | Free | Chief Executive Officer | 6,10,720 | 0.1769% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.24% | -10.27% | +3.15% | -59.57% | 46Cr | |
| -6.60% | -8.56% | +42.79% | +64.16% | 6.9TCr | |
| -4.09% | -0.11% | +2.31% | +54.81% | 5.31TCr | |
| +0.03% | +5.56% | +10.18% | +41.75% | 5.08TCr | |
| -1.53% | +2.70% | +29.72% | +34.13% | 4.46TCr | |
| -1.34% | +4.12% | +16.05% | +112.18% | 4.25TCr | |
| -5.97% | -6.22% | +258.21% | +421.57% | 4.06TCr | |
| +6.53% | +8.02% | +15.74% | +53.94% | 3.09TCr | |
| -0.90% | -10.49% | +31.48% | -1.63% | 2.54TCr | |
| -2.76% | -9.54% | -16.53% | -9.55% | 2.27TCr | |
| Average | -1.89% | -1.37% | +39.31% | +71.18% | 3.8TCr | |
| Weighted average by Cap. | -2.43% | -0.11% | +44.69% | +90.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34L 30.22L 28.01L 25.49L 48.09L 32Cr 48.86L 3.37Cr 1.32Cr 17Cr 1.28Cr 1.25Cr 54Cr | 1.21Cr 1.07Cr 99.57L 90.6L 1.71Cr 114.7Cr 1.74Cr 12Cr 4.69Cr 60Cr 4.54Cr 4.44Cr 190.81Cr |
| Net income | -19Cr -16Cr -15Cr -14Cr -26Cr -1.76TCr -27Cr -183.35Cr -72Cr -916.94Cr -69Cr -68Cr -2.92TCr | -22Cr -20Cr -18Cr -16Cr -31Cr -2.09TCr -32Cr -217.71Cr -85Cr -1.09TCr -83Cr -81Cr -3.47TCr |
| Net Debt | -20Cr -17Cr -16Cr -15Cr -28Cr -1.87TCr -28Cr -194.62Cr -76Cr -973.3Cr -74Cr -72Cr -3.1TCr | -15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -22Cr -148.72Cr -58Cr -743.74Cr -56Cr -55Cr -2.37TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $1.310 | -2.24% | 49,18,663 |
| 15/26/15 | $1.340 | +3.08% | 45,15,192 |
| 14/26/14 | $1.300 | +0.78% | 77,36,868 |
| 13/26/13 | $1.290 | -7.86% | 65,43,528 |
| 12/26/12 | $1.400 | -4.11% | 43,16,472 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
